Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Rat
100%
Non-Steroidal Anti-Inflammatory Drug
83%
Diclofenac
77%
Prostacyclin
76%
Peroxisome Proliferator Activated Receptor Delta
75%
[4 [2 (3 Fluoro 4 Trifluoromethylphenyl) 4 Methyl 5 Thiazolylmethylthio] 2 Methylphenoxy]acetic Acid
74%
Side Effect
69%
Nitric Oxide
69%
Celecoxib
63%
Cell Nucleus Receptor
63%
Pulmonary Hypertension
61%
Thyroid Hormone Receptor
51%
Receptor
50%
PPAR Agonist
48%
Thyroid Hormone Receptor Beta
47%
Diseases
46%
Pancreas Cancer
46%
Cyclooxygenase 2
46%
Beta Adrenergic Receptor Blocking Agent
46%
Hormone Receptor Blocking Agent
46%
Inflammation
44%
Apamin
36%
Delta Opiate Receptor Agonist
34%
Acetylcholine
33%
Peroxisome Proliferator Activated Receptor
32%
Naproxen
32%
Thyroid Hormone
30%
Lipid
28%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
27%
Delta Opiate Receptor Antagonist
26%
Charybdotoxin
26%
Cyclooxygenase 1
25%
Enzymes
24%
Malignant Neoplasm
24%
Advanced Glycation End Product Receptor
23%
Toll Like Receptor 4
23%
Adenosine Triphosphate
23%
Lipopolysaccharide
23%
Hypoxia-Induced Pulmonary Hypertension
23%
Cardiovascular Risk
23%
Hyperthyroidism
23%
Heart Ventricle Hypertrophy
23%
Digestant
23%
Spontaneously Hypertensive Rat
23%
Carvedilol
23%
Toxicology
23%
Antidiabetic Agent
23%
Doxycycline
23%
Nanoformulation
23%
Periodontitis
23%
Keyphrases
Prostacyclin
69%
Thyroid Hormone Receptor
69%
Cyclooxygenase-2
66%
Cyclooxygenase-1 (COX-1)
52%
GW0742
47%
Endothelium
47%
Celecoxib
46%
Diclofenac
46%
Nitric Oxide
46%
PPAR Agonists
46%
Rat Aorta
46%
β-antagonist
46%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
46%
Vasodilation
42%
Nuclear Receptor
37%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
34%
Peroxisome Proliferator-activated Receptor
31%
COVID-19
30%
Mortality Prediction
30%
Worksheet
30%
Area under the Receiver Operating Characteristic (AUROC)
29%
Lipid Mediators
28%
Development Cohort
27%
Mesenteric Vessels
27%
Retrospective Cohort Study
26%
Logistic Regression
26%
Kidney
26%
In Silico Methods
25%
Diabetic Rats
25%
S100P
23%
Pulmonary Artery
23%
Online Self
23%
Self-marking
23%
Endothelium-dependent Vasodilation
23%
Toll-like
23%
Coursework
23%
P2X Receptors
23%
Receptor Antagonist
23%
Endothelium-derived Hyperpolarizing Factor
23%
Inflammation
23%
First Year
23%
Science Learning
23%
Aspirin
23%
Enoic Acid
23%
Molecular Techniques
23%
Cyclooxygenase Isoforms
23%
Hormone Function
23%
Vascular Function
23%
Off-target Interactions
23%
Human Vascular Smooth muscle Cells
23%
Medicine and Dentistry
Vasodilatation
28%
Endothelium
27%
Diabetes
26%
Endothelial Cell
25%
Neuropathy
23%
Doxycycline
23%
Periodontal
23%
Infection
23%
Cyclooxygenase 1
23%
Prostaglandin Synthase
23%
Periodontitis
23%
Lung Slice
23%
Glycemic Control
23%
Adenosine Triphosphate
23%
Photochemotherapy
23%
Influenza A
23%
Influenza B
23%
Purinergic P2Y Receptor
23%
Purinergic P2X1 Receptor
23%
Maturity Onset Diabetes of the Young
23%
Digestant
23%
Purinergic P2X Receptor
23%
Spontaneously Hypertensive Rat
23%
Carvedilol
23%
Heart Development
23%
Ventricular Hypertrophy
23%
Thyroid Hormone Receptor
23%
Prostacyclin
23%
Hormone Receptor Blocking Agent
23%
Antiinfective Agent
23%
Metabolite
23%
Notch
23%
Superoxide
23%
Pulse Rate
23%
Toll Like Receptor 4
23%
Methylglyoxal
23%
Severe Acute Respiratory Syndrome Coronavirus 2
23%
Nitric Oxide
22%
Fatty Acid
18%
Cyclooxygenase 2
17%
Acetylcholine
17%
Antibiotics
16%
Apamin
13%
Enzyme
13%
Charybdotoxin
13%
Beraprost
13%
[4 [2 (3 Fluoro 4 Trifluoromethylphenyl) 4 Methyl 5 Thiazolylmethylthio] 2 Methylphenoxy]acetic Acid
13%
Scaling and Root Planing
13%
Gum Disease
13%
Smooth Muscle Cell
11%
